technology

LONDON (Reuters) - The world's leading drug companies are turning to artificial intelligence to improve the hit-and-miss business of finding new medicines, with GlaxoSmithKline unveiling a new $43 million deal in the field on Sunday.


from Reuters: Technology News http://ift.tt/2t4am7E
Previous
Next Post »

StatCounter